These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2801311)

  • 41. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
    Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
    J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor.
    Seow WK; Ferrante A; Summors A; Thong YH
    Life Sci; 1992; 50(8):PL53-8. PubMed ID: 1310515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.
    Winkler JD; Fonteh AN; Sung CM; Heravi JD; Nixon AB; Chabot-Fletcher M; Griswold D; Marshall LA; Chilton FH
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1338-47. PubMed ID: 7562506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
    Rainsford KD; Ying C; Smith FC
    J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production.
    Griswold DE; Hillegass LM; Breton JJ; Esser KM; Adams JL
    Drugs Exp Clin Res; 1993; 19(6):243-8. PubMed ID: 8013267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002.
    Griswold DE; Webb E; Schwartz L; Hanna N
    Inflammation; 1987 Jun; 11(2):189-99. PubMed ID: 3108157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with interleukin-1-synthesis inhibitors.
    Rainsford KD; Ying C; Smith F
    J Pharm Pharmacol; 1996 Jan; 48(1):46-52. PubMed ID: 8722494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Augmentation of glucocorticoid action on human monocytes by interleukin-4.
    Hart PH; Whitty GA; Burgess DR; Croatto M; Hamilton JA
    Lymphokine Res; 1990; 9(2):147-53. PubMed ID: 2110990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes.
    Chang DM; Baptiste P; Schur PH
    J Rheumatol; 1990 Sep; 17(9):1148-57. PubMed ID: 1981242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.
    Unangst PC; Connor DT; Cetenko WA; Sorenson RJ; Kostlan CR; Sircar JC; Wright CD; Schrier DJ; Dyer RD
    J Med Chem; 1994 Jan; 37(2):322-8. PubMed ID: 8295221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes.
    Griswold DE; Martin LD; Badger AM; Breton J; Chabot-Fletcher M
    Inflamm Res; 1998 Feb; 47(2):56-61. PubMed ID: 9535542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of suppressive effects of a new anti-inflammatory compound, FR167653, on production of PGE2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin.
    Kawano T; Ogushi F; Tani K; Endo T; Ohmoto Y; Hayashi Y; Sone S
    J Leukoc Biol; 1999 Jan; 65(1):80-6. PubMed ID: 9886249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro.
    Hoffman T; Lee YL; Lizzio EF; Tripathi AK; Jessop JJ; Taplits M; Abrahamsen TG; Carter CS; Puri J
    Clin Immunol Immunopathol; 1991 Mar; 58(3):399-408. PubMed ID: 1900463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukotrienes do not regulate interleukin 1 production by activated macrophages.
    Parkar BA; McCormick ME; Foster SJ
    Biochem Biophys Res Commun; 1990 Jun; 169(2):422-9. PubMed ID: 2357213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis.
    Griswold DE; Hillegass LM; Meunier PC; DiMartino MJ; Hanna N
    Arthritis Rheum; 1988 Nov; 31(11):1406-12. PubMed ID: 3142488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis.
    Otterness IG; Bliven ML; Downs JT; Natoli EJ; Hanson DC
    Cytokine; 1991 Jul; 3(4):277-83. PubMed ID: 1873477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of anti-inflammatory medication on monocyte response to titanium particles.
    Sun JS; Lin FH; Tsuang YH; Chen LT; Hong RC; Chang WH; Liu HC
    J Biomed Mater Res; 2000 Dec; 52(3):509-16. PubMed ID: 11007619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of antiinflammatory drugs on the release from porcine synovial tissue in vitro of interleukin 1 like cartilage degrading activity.
    Rainsford KD
    Agents Actions; 1987 Aug; 21(3-4):337-40. PubMed ID: 3500595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes.
    Furse RK; Rossetti RG; Zurier RB
    J Immunol; 2001 Jul; 167(1):490-6. PubMed ID: 11418687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.